BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 38051365)

  • 1. Antibiofilm activity of mesoporous silica nanoparticles against the biofilm associated infections.
    Sil M; Mukherjee D; Goswami A; Nag M; Lahiri D; Bhattacharya D
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3617-3633. PubMed ID: 38051365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles as diagnostic and therapeutic tools: how can they combat bacterial infection?
    Şen Karaman D; Manner S; Rosenholm JM
    Ther Deliv; 2018 Mar; 9(4):241-244. PubMed ID: 29495945
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyethylenimine-grafted mesoporous silica nanocarriers markedly enhance the bactericidal effect of curcumin against Staphylococcus aureus biofilm.
    Pamukçu A; Erdoğan N; Şen Karaman D
    J Biomed Mater Res B Appl Biomater; 2022 Nov; 110(11):2506-2520. PubMed ID: 35735075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quorum sensing inhibitors as anti-biofilm agents.
    Brackman G; Coenye T
    Curr Pharm Des; 2015; 21(1):5-11. PubMed ID: 25189863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-Functionalized Mesoporous Silica Nanoparticles to Target
    Devlin H; Fulaz S; Hiebner DW; O'Gara JP; Casey E
    Int J Nanomedicine; 2021; 16():1929-1942. PubMed ID: 33727807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
    Colilla M; Vallet-Regí M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on
    Juszczuk-Kubiak E
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial and antibiofilm activities of meropenem loaded-mesoporous silica nanoparticles against carbapenem-resistant
    Memar MY; Yekani M; Ghanbari H; Nabizadeh E; Vahed SZ; Dizaj SM; Sharifi S
    J Biomater Appl; 2021 Oct; 36(4):605-612. PubMed ID: 33722086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms.
    Lu MM; Ge Y; Qiu J; Shao D; Zhang Y; Bai J; Zheng X; Chang ZM; Wang Z; Dong WF; Tang CB
    Int J Nanomedicine; 2018; 13():7697-7709. PubMed ID: 30538453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular Assemblies of Heterogeneous Mesoporous Silica Nanoparticles to Co-deliver Antimicrobial Peptides and Antibiotics for Synergistic Eradication of Pathogenic Biofilms.
    Yu Q; Deng T; Lin FC; Zhang B; Zink JI
    ACS Nano; 2020 May; 14(5):5926-5937. PubMed ID: 32310641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring Nanoparticle-Biofilm Interactions to Increase the Efficacy of Antimicrobial Agents Against
    Fulaz S; Devlin H; Vitale S; Quinn L; O'Gara JP; Casey E
    Int J Nanomedicine; 2020; 15():4779-4791. PubMed ID: 32753866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica-Based Materials with Bactericidal Properties.
    Bernardos A; Piacenza E; Sancenón F; Hamidi M; Maleki A; Turner RJ; Martínez-Máñez R
    Small; 2019 Jun; 15(24):e1900669. PubMed ID: 31033214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Strategies to Combat Bacterial Biofilms.
    Hemmati F; Rezaee MA; Ebrahimzadeh S; Yousefi L; Nouri R; Kafil HS; Gholizadeh P
    Mol Biotechnol; 2021 Jul; 63(7):569-586. PubMed ID: 33914260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of Bacteria and Bacterial Products as Antibiofilm and Antiquorum Sensing Drugs Against Pathogenic Bacteria.
    Khan F; Oloketuyi SF; Kim YM
    Curr Drug Targets; 2019; 20(11):1156-1179. PubMed ID: 31020938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
    González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
    Sarkar S; Ekbal Kabir M; Kalita J; Manna P
    Chembiochem; 2023 Apr; 24(7):e202200672. PubMed ID: 36719179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms.
    Borges A; Abreu AC; Dias C; Saavedra MJ; Borges F; Simões M
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin Loaded Amino-Functionalized MCM-48 Mesoporous Silica Nanoparticles as a Promising Drug Carrier in Bone Substitutes for Bacterial Infection Management.
    Rahaman SN; Pathmanapan S; Sidharthan A; Anandasadagopan SK
    Appl Biochem Biotechnol; 2023 Nov; 195(11):6607-6632. PubMed ID: 36892681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.